CRYSTALLINE MODIFICATION III OF N-(4-(5-DIMETHYLAMINO-NAPHTHALINE-1-SULFONYLAMINO)-PHENYL)-3-HYDROXY-2,2-DIMETHYL-PROPIONAMIDE

摘要

Crystalline form III of N - (4 - (5 - dimetilaminoaftalen - 1 - sulfonylamino) phenyl) - 3 - hydroxy - 2.2 - dimetilpropionamida (dnsp) formula.Compositions containing IT, and its use for the Treatment or prophylaxis of Viral Infections, especially of the Human cytomegalovirus.The preparation method is to suspend the Crystalline Form I of the dnsp in water or Organic Solvents and at a temperature of 0 Degree c to 60 degrees C.